Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Miguel Ángel Calleja, Andrés Navarro, José María Serratosa, Manuel Toledo, Vicente Villanueva, Silvia Subías Labazuy & Alicia Gil. (2022) Determination of the economically justifiable price of cenobamate in the treatment of focal-onset seizures in adult patients with drug-resistant epilepsy in Spain. Expert Review of Pharmacoeconomics & Outcomes Research 22:7, pages 1127-1136.
Read now
Read now
Isabel Barrachina-Martinez, David Vivas-Consuelo & Francisco Reyes-Santias. (2021) Cost-utility model of brivaracetam in the adjunctive treatment of patients with epilepsy in Spain. Expert Review of Pharmacoeconomics & Outcomes Research 21:5, pages 1081-1090.
Read now
Read now
Zhixiao Wang, Xuan Li, Annette Powers & Jose E Cavazos. (2015) Outcomes associated with switching from monotherapy to adjunctive therapy for patients with partial onset seizures. Expert Review of Pharmacoeconomics & Outcomes Research 15:2, pages 349-355.
Read now
Read now
Articles from other publishers (6)
Vicente Villanueva, José M. Serratosa, Manuel Toledo, Miguel Ángel Calleja, Andrés Navarro, Joel Sabaniego, Paloma Pérez-Domper, Elena Álvarez-Barón, Silvia Subías & Alicia Gil. (2023) Number needed to treat and associated cost analysis of cenobamate versus third-generation anti-seizure medications for the treatment of focal-onset seizures in patients with drug-resistant epilepsy in Spain. Epilepsy & Behavior 139, pages 109054.
Crossref
Crossref
Sudhir C. Sarangi, Nivendeep Kaur & Manjari Tripathi. (2020) Need for pharmacoeconomic consideration of antiepileptic drugs monotherapy treatment in persons with epilepsy. Saudi Pharmaceutical Journal 28:10, pages 1228-1237.
Crossref
Crossref
Chengjuan Du, Jianhong Wang, Xianping Liu, Huiming Li, Daoying Geng, Luodan Yu, Yu Chen & Jun Zhang. (2020) Construction of Pepstatin A-Conjugated ultrasmall SPIONs for targeted positive MR imaging of epilepsy-overexpressed P-glycoprotein. Biomaterials 230, pages 119581.
Crossref
Crossref
Jesse Fishman, Melinda Martin, David M. Labiner, Carolyn R. Lew & Barbara H. Johnson. (2019) Healthcare resource utilization and costs before and after lacosamide initiation as adjunctive therapy among patients with epilepsy in the United States. Epilepsy & Behavior 99, pages 106331.
Crossref
Crossref
Isabel Barrachina-Martínez, David Vivas-Consuelo & Anna Piera-Balbastre. (2017) Budget Impact Analysis of Brivaracetam Adjunctive Therapy for Partial-Onset Epileptic Seizures in Valencia Community, Spain. Clinical Drug Investigation 38:4, pages 353-363.
Crossref
Crossref
Kristian Bolin & Lars Forsgren. (2012) The Cost Effectiveness of Newer Epilepsy Treatments. PharmacoEconomics 30:10, pages 903-923.
Crossref
Crossref